The Quantellect read.As of Nov 19, 2026, 17 active firms cover Akamai Technologies Inc: 10 rate it Buy or better, 7 sit at Neutral, and 0 rate it Sell or worse, a buy consensus. Targets range widely, $100.00 to $225.00 (about 2.3x), a sign of real disagreement on valuation. The average target of $153.59 sits 67% above the current $91.72. The rating mix has stayed broadly stable, with Buy-side ratings edging up from 9 to 10 over recent months. On the fundamentals, the Street sees revenue growth near 7% this year and 10% next, consensus EPS building from about $1.50 next quarter toward $6.93 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS17 active firms
Buy
Strong Buy16%
Buy953%
Neutral741%
Sell00%
Strong Sell00%
Based on 17 active firms as of Nov 19, 2026 (365-day activity window).
12-MONTH PRICE TARGET
$153.59
+67.5% upside
Average target across 17 active firms as of Nov 19, 2026 vs $91.72 current
Highest Target$225.00
Average Target$153.59
Lowest Target$100.00
Detailed analyst forecasts for AKAM
Showing 1–17 of 17 named analysts shown · 17 active firms in the rating projection
As of Nov 19, 2026, 10 of 17 active firms rate AKAM a Buy (7 Neutral, 0 Sell). Historical months are month-end active-firm counts; the current month uses its actual as-of date.
AKAM EPS & revenue forecast
EPS · NEXT QUARTER
$1.50
Range $1.33 – $1.76 · 18 analysts · -7% YoY
Next period, 18 analysts expect Akamai Technologies Inc to earn $1.50 a share (range $1.33 – $1.76), versus $1.61 a year earlier. Full-year consensus is $6.54, growing to $6.93 the year after.
REVENUE · NEXT QUARTER
$1.2B
Range $1.1B – $1.2B · 18 analysts · +7% YoY
Revenue is expected to reach $1.2B (range $1.1B – $1.2B), +7.0% year-over-year. Full-year consensus is $4.5B, rising to $5.3B next year.
Top analysts covering Akamai Technologies Inc
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on AKAM.
#1
Samik Chatterjee
JP Morgan · Rank #164
Neutral
$167.00+82.1% to target
Overall win rate
46%
+ Follow
#2
Frank Louthan
Raymond James · Rank #244
Buy
$170.00+85.3% to target
Overall win rate
44%
+ Follow
#3
Mike Cikos
Needham · Rank #296
Neutral
No targeton AKAM
Overall win rate
45%
+ Follow
#4
Rishi Jaluria
RBC Capital · Rank #389
Neutral
$85.00-7.3% to target
Overall win rate
36%
+ Follow
#5
James Fish
Piper Sandler
Buy
$120.00+30.8% to target
Coverage
—
+ Follow
AKAM stock forecast FAQ
What is AKAM's average 12-month price target?+
The 17 active firms with a live target average $153.59 for Akamai Technologies Inc over the next 12 months, ranging from a $225.00 high to a $100.00 low, as of Nov 19, 2026.
Is AKAM stock a Buy, Sell or Neutral right now?+
The current consensus is Buy. Of the 17 active firms as of Nov 19, 2026, 10 rate it Buy or Strong Buy, 7 rate it Neutral, and 0 rate it Sell or Strong Sell.
What are the highest and lowest price targets for AKAM?+
The Street-high target is $225.00 (Guggenheim), and the Street-low is $100.00 (UBS). The average of all 17 active-firm targets is $153.59.
How many active Wall Street firms cover AKAM?+
17 active firms have a recognized rating on Akamai Technologies Inc as of Nov 19, 2026, and 17 active firms carry a live 12-month price target.
Who is the most accurate analyst covering AKAM?+
Among analysts who currently cover AKAM, Samik Chatterjee of JP Morgan has the strongest overall Quantellect track record (Rank #164). Their current call is Neutral with a $167.00 target.
What is Akamai Technologies Inc's projected EPS for next quarter?+
The consensus estimate is $1.50 per share (range $1.33 – $1.76) across 18 analysts. Full-year EPS is projected at $6.54, rising to $6.93 the following year.
How much revenue is Akamai Technologies Inc expected to report next quarter?+
Consensus revenue is $1.2B (range $1.1B – $1.2B). Full-year revenue is projected at $4.5B, growing to $5.3B next year.
Have analysts been upgrading or downgrading AKAM lately?+
As of Nov 19, 2026, 10 of 17 active firms rate AKAM a Buy (7 Neutral, 0 Sell). Historical months are month-end active-firm counts; the current month uses its actual as-of date.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their AKAM calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.